WallStreetZenWallStreetZen

NASDAQ: RIGL
Rigel Pharmaceuticals Inc Stock Ownership - Who owns Rigel Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rigel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dean L. SchornoEVP Chief Financial Officer2025-12-222,846$24.20
$68.87kBuy
Dean L. SchornoEVP Chief Financial Officer2025-12-221,987$20.00
$39.74kBuy
Dean L. SchornoEVP Chief Financial Officer2025-12-221,667$18.70
$31.17kBuy
Raul R. RodriguezCEO President2025-02-054,400$21.93
$96.47kSell
Raymond J. FureyEVP GC CCO Corp Sec2025-02-051,339$21.93
$29.36kSell
David A. SantosEVP Chief Commercial Officer2025-02-051,796$21.93
$39.38kSell
Dean L. SchornoEVP Chief Financial Officer2025-02-051,734$21.93
$38.02kSell
Raymond J. FureyEVP GC CCO Corp Sec2025-02-041,448$20.92
$30.29kSell
David A. SantosEVP Chief Commercial Officer2025-02-042,125$20.92
$44.46kSell
Dean L. SchornoEVP Chief Financial Officer2025-02-042,036$20.92
$42.60kSell

1 of 2

RIGL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RIGL insiders and whales buy or sell their stock.

RIGL Shareholders

What type of owners hold Rigel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P91.78%16,660,120$713.55MInsider
James E. Flynn37.14%6,742,289$288.77MInsider
Blackrock Inc9.50%1,724,898$73.88MInstitution
Vanguard Group Inc5.75%1,043,123$44.68MInstitution
Goldman Sachs Group Inc4.06%737,035$31.57MInstitution
Armistice Capital LLC3.99%724,000$31.01MInstitution
Acadian Asset Management LLC3.78%685,718$29.37MInstitution
Marshall Wace LLP3.31%601,333$25.76MInstitution
Capitolis Liquid Global Markets LLC3.26%591,553$25.34MInstitution
State Street Corp3.05%554,318$23.74MInstitution

1 of 3

RIGL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RIGL37.73%62.27%Net SellingNet Buying
GHRS71.79%0.00%
REPL66.37%33.63%Net SellingNet Selling
ARVN74.71%25.29%Net SellingNet Selling
ORIC83.26%16.74%Net SellingNet Selling
View Top Biotech Stocks

Rigel Pharmaceuticals Stock Ownership FAQ

Who owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals (NASDAQ: RIGL) is owned by 82.76% institutional shareholders, 136.57% Rigel Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Rigel Pharmaceuticals shareholder, owning 16.66M shares representing 91.78% of the company. Bvf Partners L P's Rigel Pharmaceuticals shares are currently valued at $713.55M.

If you're new to stock investing, here's how to buy Rigel Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.